HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roland Haubner Selected Research

Neoplasm Metastasis (Metastasis)

10/2018Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
2/2009Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice.
1/2009Radiolabelled RGD peptides and peptidomimetics for tumour targeting.
7/2006Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
8/2005Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.
3/2005Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roland Haubner Research Topics

Disease

27Neoplasms (Cancer)
11/2019 - 10/2003
6Neoplasm Metastasis (Metastasis)
10/2018 - 03/2005
3Melanoma (Melanoma, Malignant)
11/2019 - 11/2006
3Atherosclerotic Plaque (Atheroma)
10/2008 - 05/2005
2Prostatic Neoplasms (Prostate Cancer)
03/2023 - 10/2018
2Hypoxia (Hypoxemia)
09/2010 - 04/2008
2Hypersensitivity (Allergy)
08/2009 - 01/2005
1Hemochromatosis (Bronze Diabetes)
01/2020
1Iron Overload
01/2020
1type 4 Hemochromatosis
01/2020
1Thyroid Neoplasms (Thyroid Cancer)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
10/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2016
1Leukemia
04/2012
1Ischemia
06/2011
1Glioma (Gliomas)
12/2009
1Glioblastoma (Glioblastoma Multiforme)
12/2009
1Autoimmune Diseases (Autoimmune Disease)
08/2009
1Bacterial Infections (Bacterial Infection)
08/2009
1Rupture
10/2008
1Neointima
10/2008
1Vascular System Injuries
10/2008
1Unstable Angina
07/2008
1Myocardial Infarction
07/2008
1Fibrosis (Cirrhosis)
07/2008
1Atherosclerosis
07/2008
1Carcinogenesis
06/2008
1Carcinoma (Carcinomatosis)
06/2008
1Infertility (Sterility)
11/2007
1Arthritis (Polyarthritis)
06/2007
1Cardiovascular Diseases (Cardiovascular Disease)
11/2006
1Thrombosis (Thrombus)
05/2005
1Inflammation (Inflammations)
01/2005

Drug/Important Bio-Agent (IBA)

14IntegrinsIBA
11/2019 - 11/2006
10Peptides (Polypeptides)IBA
11/2019 - 01/2004
7Integrin alphaVbeta3IBA
12/2009 - 01/2004
5Integrin beta3 (GPIIIa)IBA
12/2009 - 01/2005
3Radioisotopes (Radionuclides)IBA
03/2023 - 07/2008
3Arginine (L-Arginine)FDA Link
11/2019 - 01/2005
3Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2019 - 01/2005
31- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
10/2016 - 02/2015
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2014 - 02/2009
3arginyl-glycyl-aspartic acidIBA
06/2011 - 03/2007
2Cyclic PeptidesIBA
02/2015 - 01/2005
2Type I Tumor Necrosis Factor ReceptorsIBA
08/2009 - 06/2008
2Aspartic Acid (Aspartate)FDA Link
02/2009 - 01/2005
2Integrin alphaVIBA
01/2009 - 07/2006
2Collagen ReceptorsIBA
10/2008 - 05/2005
2CytokinesIBA
07/2008 - 06/2008
1PSMA I&TIBA
03/2023
1Ferritins (Ferritin)IBA
01/2020
1metal transporting protein 1 (ferroportin)IBA
01/2020
1IronIBA
01/2020
1HepcidinsIBA
01/2020
1Cholecystokinin B ReceptorIBA
01/2019
1gallium 68 PSMA-11IBA
10/2018
1Sodium Fluoride (Ossin)FDA Link
10/2018
1Gallium-68IBA
01/2017
1fusigenIBA
10/2016
1Chelating AgentsIBA
02/2015
1SiderophoresIBA
02/2015
1Neurotensin Receptors (Neurotensin Receptor)IBA
04/2014
1GlycopeptidesIBA
02/2014
1Liposomes (Liposome)IBA
01/2012
1aspartic acid glycine arginineIBA
08/2011
1Receptor for Advanced Glycation End ProductsIBA
06/2011
1cyclo(arginylglycyl)IBA
09/2010
1tyrosyl-lysineIBA
09/2010
1Amino AcidsFDA Link
09/2010
1RadiopharmaceuticalsIBA
09/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
08/2009
1Biomarkers (Surrogate Marker)IBA
04/2009
1Dasatinib (BMS 354825)FDA Link
04/2009
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2009
1src-Family KinasesIBA
04/2009
1AcidsIBA
02/2009
1Apolipoproteins E (ApoE)IBA
10/2008
1CollagenIBA
10/2008
1Lipoproteins (Lipoprotein)IBA
07/2008
1LectinsIBA
07/2008
1Metalloproteases (Metalloproteinases)IBA
07/2008
1Tumor Viral Antigens (Large T Antigen)IBA
06/2008
1ChemokinesIBA
06/2008
1Cytotoxins (Cytolysins)IBA
04/2008
1azomycinIBA
04/2008
1fluoroazomycin arabinosideIBA
04/2008
1carbogenIBA
04/2008
1EndotoxinsIBA
11/2007
1Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA
06/2007
1AutoantibodiesIBA
06/2007
1Glycoproteins (Glycoprotein)IBA
05/2005
1HaptensIBA
01/2005

Therapy/Procedure

7Therapeutics
03/2023 - 01/2004
3Radiotherapy
01/2019 - 09/2010
2Gamma Cameras (Gamma Camera)
11/2006 - 01/2004
1Aftercare (After-Treatment)
04/2014
1Radioimmunotherapy
04/2012
1Stem Cell Transplantation
04/2012
1Intravenous Injections
02/2009
1Secondary Prevention
07/2008